OAB Delivery Catheter

K253422 · Cognition Medical Corp. · QJP · Oct 2, 2026 · Cardiovascular

Device Facts

Record IDK253422
Device NameOAB Delivery Catheter
ApplicantCognition Medical Corp.
Product CodeQJP · Cardiovascular
Decision DateOct 2, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.1250
Device ClassClass 2

Indications for Use

The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature.

Device Story

Variable stiffness, single-lumen catheter; reinforced with metal braid, coil, and polymer layers; features tapered tip with radiopaque markers and distal hydrophilic coating. Used in neurovascular procedures; inserted into compatible access catheter; advanced over neurovascular guidewire under fluoroscopic guidance. Enables infusion of diagnostic agents and delivery of interventional devices. Operated by physicians in clinical settings. Provides mechanical pathway for interventional tools; facilitates navigation through complex vasculature; enhances procedural efficiency.

Clinical Evidence

No clinical data. Substantial equivalence supported by extensive bench performance testing, including dimensional verification, air/liquid leak, bond strength, flow rate, tip flexibility, torque strength, static burst, corrosion, hub compatibility, particulate generation, simulated use, kink resistance, coating integrity/lubricity, and radiopacity. Biocompatibility testing performed per ISO 10993-1 (cytotoxicity, sensitization, irritation, pyrogenicity, acute systemic toxicity, and hemocompatibility).

Technological Characteristics

Single-lumen catheter; metal braid/coil/polymer construction; hydrophilic coating (66 cm). Dimensions: 0.021" ID; 0.062"-0.070" OD. Sterilized via Ethylene Oxide (ISO 11135). Hubs compliant with ISO 80369-7/20. Mechanical sensing/actuation via manual manipulation under fluoroscopy.

Indications for Use

Indicated for patients requiring intravascular infusion of diagnostic agents (e.g., contrast media) or delivery of interventional devices (e.g., distal access catheters) within peripheral, coronary, and neurovasculature.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

Reference Devices

Submission Summary (Full Text)

{1} **FDA** U.S. FOOD & DRUG ADMINISTRATION October 2, 2026 Cognition Medical Corp. % Robert Herrmann, Ph.D. Director, Neurointerventional Regulatory Affairs MCRA, LLC 803 7th Street, NW, 3rd Floor Washington, DC 20001 Re: K253422 Trade/Device Name: OAB Delivery Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: QJP, DQY Dated: September 1, 2026 Received: September 1, 2026 Dear Robert Herrmann: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} K253422 - Robert Herrmann, Ph.D. Page 2 Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the {3} K253422 - Robert Herrmann, Ph.D. Page 3 Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, NAIRA MURADYAN -S Naira Muradyan, PhD Assistant Director DHT5A: Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {4} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K253422 | ? | | Please provide the device trade name(s). | | ? | | OAB Delivery Catheter | | | | Please provide your Indications for Use below. | | ? | | The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature. | | | | Please select the types of uses. | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | {5} K253422 COGNITION MEDICAL Page 1 of 7 # 510(k) SUMMARY # Submitter's Name and Address, Contact Person and Date Prepared Cognition Medical Corporation 103 Calibre Woods Dr NE Atlanta, GA 30329 Phone: (617) 682-6019 Email: alex@cognitionmedical.com Contact: Alex Turjman Phone: (617) 682-6019 Email: alex@cognitionmedical.com Date Prepared: September 30, 2026 # 1. Device Name and Classification Trade name: OAB Delivery Catheter Common name: Percutaneous Catheter Regulation: 21 CFR 870.1250 - Percutaneous Catheter Regulatory class: II Product code: QJP, DQY # 2. Predicate Device Submission Number: K230609 Trade name: NG Delivery Catheter Regulation: 21 CFR 870.1250 – Percutaneous Catheter Regulatory class: II Product code: QJP, DQY # 3. Reference Device Submission Number: K172014 Trade name: Wedge Microcatheter Regulation: 21 CFR 870.1250 – Percutaneous Catheter Regulatory class: II Product code: DQY # 4. Device Description The OAB Delivery Catheter is a variable stiffness single lumen catheter reinforced with metal braid, coil and polymer layers, with a tapered tip delineated by radiopaque markers. The distal shaft of the OAB Delivery Catheter has a hydrophilic coating. The device is provided sterile and non-pyrogenic and is intended for single use only. During use, a neurovascular guidewire may be inserted into the OAB Delivery Catheter. The OAB Delivery Catheter is inserted into a compatible access catheter. The OAB Delivery Catheter and access catheter are advanced to the targeted location under fluoroscopy using common endovascular techniques. The lumen of the catheter extends from the proximal luer port to the distal tip with a minimum inner diameter (ID) of 0.021" and a maximum outer diameter (OD) of 0.070" for the larger version and 0.062" for the smaller version. {6} K253422 COGNITION MEDICAL Page 2 of 7 ##### 5. Indications for Use The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the neurovasculature. ##### 6. Comparison of Technological Characteristics with the Predicate Device The subject and predicate devices have similar dimensions and principles of operation. Both subject and predicate devices have a hydrophilic coating, and both use similar packaging systems. | Attribute | Predicate Device: NG Delivery Catheter (K230609) | Reference Device: Wedge Microcatheter (K172014) | Subject Device: OAB Delivery Catheter (K253422) | | --- | --- | --- | --- | | Classification | Class II | Class II | Class II | | Product Code | QJP, DQY | DQY | QJP, DQY | | Manufacturer | Balt USA, LLC | MicroVention, Inc. | Cognition Medical Corp. | | Intended Use / Indications for Use | The NG Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the | The Wedge Microcatheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as the | The OAB Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as distal access catheters, in the | {7} K253422 COGNITION MEDICAL Page 3 of 7 | | neurovasculature. | SOFIA 6F Catheter, in the neurovasculature. | neurovasculature. | | --- | --- | --- | --- | | Working Lengths | 152 cm | 158-160 cm | 154 cm | | Distal Tip Configuration | Tapered Tip | Bulb with extension | Tapered tip Tapered tip with extension | | Sterilization Method | Ethylene Oxide | Ethylene Oxide | Same | | Single Use Device | Yes | Yes | Same | | Catheter ID | 0.021” | 0.021” | Same | | Catheter OD, Max | 0.059” (1.50 mm) – 0.069” (1.75 mm) | 0.028” - 0.034” (0.71-0.86 mm) 0.068” (1.73 mm) for bulb feature (~1 cm) | 0.062” (1.63 mm) – 0.070” (1.83 mm) | | Coating | Distal hydrophilic coating (60 cm) | Distal hydrophilic coating (110-115 cm) | Distal hydrophilic coating (66 cm) | | Packaging Configuration | Microcatheter is placed in a dispenser hoop and accessories on a mounting card that is then inserted into the pouch. The pouch is then placed inside a carton box. | Microcatheter is placed in a dispenser hoop and accessories on a mounting card that is then inserted into the pouch. The pouch is then placed inside a carton box. | The OAB Delivery Catheter is placed in a dispenser hoop that is then inserted into a pouch. The pouch is then placed inside a carton box. | ### 7. Testing The OAB Delivery Catheter was evaluated using the following non-clinical testing. Performance Testing – Bench The following bench performance testing was performed to demonstrate the OAB Delivery Catheter performs as intended. | Test | Description | Results | | --- | --- | --- | | Dimensional Verification | This test verified the dimensional specifications. | Pass – all samples met the pre-determined acceptance criteria. | {8} K253422 COGNITION MEDICAL Page 4 of 7 | Visual Inspection | This test verified that the visual surface requirements were met. | Pass – all samples met the pre-determined acceptance criteria. | | --- | --- | --- | | Air Leak | The catheter was tested according to ISO 10555-1, Annex I. | Pass – all samples met the pre-determined acceptance criteria. | | Liquid Leak | The catheter was tested according to ISO 10555-1, Annex C. | Pass – all samples met the pre-determined acceptance criteria. | | Catheter Bond Strength | The catheter was evaluated to verify the peak bond strength meets specifications. | Pass – all samples met the pre-determined acceptance criteria. | | Flow Rate | The flow rate through the catheter was measured per ISO 10555-1 Annex E and compared to the reference device. | Pass – all samples met the pre-determined acceptance criteria. | | Tip Flexibility | The flexibility of the catheter tip was verified. The catheter stiffness profile was compared to the predicate device. | Pass – all samples met the pre-determined acceptance criteria. | | Torque Strength | The catheter was evaluated for torque strength by rotating the test samples in an anatomical model with the distal tip fixed and recording the number of rotations to failure. | Pass – all samples met the pre-determined acceptance criteria. | | Static Burst | The catheter was tested according to ISO 10555-1, Annex F. | Pass – all samples met the pre-determined acceptance criteria. | | Corrosion | The catheter was tested according to ISO 10555-1, Annex A. | Pass – all samples met the pre-determined acceptance criteria. | | Hub Compatibility | The hub was tested according to ISO 80369-7 and ISO 80369-20. | Pass – all samples met the pre-determined acceptance criteria. | | Particulate | The catheter was evaluated for particulate generation during simulated use in an anatomical model and compared to predicate and reference devices. | Pass – all samples met the pre-determined acceptance criteria. | | Simulated Use | The catheter was evaluated in a simulated anatomical model for ease of preparation, accessory device compatibility, trackability, lubricity and kink resistance. | Pass – all samples met the pre-determined acceptance criteria. | | Kink Resistance | The catheter was evaluated for resistance to kinking around bends with clinically relevant radii. | Pass – all samples met the pre-determined acceptance criteria. | {9} K253422 COGNITION MEDICAL Page 5 of 7 | Coating Integrity | The catheter was evaluated for coating integrity and coverage. | Pass – all samples met the pre-determined acceptance criteria. | | --- | --- | --- | | Coating Lubricity and Durability | The catheter was evaluated for frictional forces and coating durability. | Pass – all samples met the pre-determined acceptance criteria. | | Radiopacity | The catheter was visualized under fluoroscopy to demonstrate equivalence with predicate in terms of radiopacity. | Pass – all samples met the pre-determined acceptance criteria. | ### Biocompatibility testing Biocompatibility testing was conducted according to FDA Guidance “Use of International Standard ISO 10993-1, “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process”.” The tests performed are listed below. | Test | Test Summary | Conclusions | | --- | --- | --- | | Cytotoxicity – MEM Elution Test | The device was evaluated for potential cytotoxic effects following ISO 10993-5 guidelines. | Non-cytotoxic | | Sensitization – ISO Guinea Pig Maximization Sensitization | The device was evaluated for the potential to cause sensitization in guinea pigs based on ISO 10993-10. The test animals showed no evidence of inducing sensitization. | Non-sensitizing | | Irritation – Intracutaneous Reactivity | The device was evaluated for the potential to cause irritation following intracutaneous injection in rabbits based on ISO 10993-23. The extracts of the test article show no evidence of irritation. | Non-irritant | | Pyrogenicity – Material Mediated Pyrogenicity Test | The device was evaluated for the potential to induce a pyrogenic response following intravenous injection in rabbits based on ISO 10993-11. The total rise of temperature was within the acceptable range. | Non-pyrogenic | | Acute Systemic Toxicity | The device was evaluated for acute systemic toxicity in mice based on ISO 10993-11. No change was observed in general conditions or in necropsy. | No systemic toxicity | {10} K253422 COGNITION MEDICAL Page 6 of 7 | Hemocompatibility - Hemolysis Testing (direct and indirect) | The device was evaluated for hemolytic potential when in contact with blood based on ISO 10993-4 and ASTM F756 standard. | The test article is non-hemolytic. | | --- | --- | --- | | Hemocompatibility – Complement Activation | The SC5b-9 assay was conducted to assess complement activation. | The test article is considered a non-activator of the complement system. | | Hemocompatibility – Thrombogenicity | Thrombogenicity was assessed using an in vitro blood flow loop based on ISO 10993-4. | The test article is thromboresistant. | | Hemocompatibility – Platelet Leukocyte Count | Platelet and leukocyte count testing was performed according to ASTM F2888 and ISO 10993-4. | Test device is hemocompatible. | | Hemocompatibility – Partial Thromboplastin Time (PTT) | PTT test performed according to ASTM F2382. | Test device does not activate the coagulation cascade. | #### Sterilization, Packaging and Shelf Life The OAB Delivery Catheter is sterilized using ethylene oxide. The sterilization cycle was validated to ensure a sterility assurance level (SAL) of \( 10^{-6} \) in accordance with ISO 11135. The OAB Delivery Catheter packaging consists of a protective hoop and pouch. Packaging validation studies were conducted to demonstrate the packaging system provides adequate protection of the device and sterility through the product life cycle. Aging studies for the device have been conducted and demonstrated a 2-year shelf life. Testing demonstrated adequate packaging and device performance. #### Animal Testing Animal testing was not deemed necessary to demonstrate substantial equivalence. #### Clinical Testing Clinical testing was deemed to be not necessary to demonstrate substantial equivalence. ## 8. Conclusions {11} K253422 COGNITION MEDICAL Page 7 of 7 The OAB Delivery Catheter and the predicate NG Delivery Catheter (K230609) have similar intended use, device operating principle, technological characteristics and indications for use. The differences in technological characteristics do not raise new questions of safety or effectiveness. The non-clinical testing demonstrates that the subject OAB Delivery Catheter performs as intended and supports substantial equivalence to the predicate device.
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...